To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

Bill: 116-hr-5382
Sponsor: full_name: Rep. Fortenberry, Jeff [R-NE-1]
Introduced: 2019-12-10
Policy area: Health
Subjects: Health care coverage and access

Prescription drugs

Retail and wholesale trades
Latest action: action_date: 2019-12-11
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2019-12-10
action_desc: Introduced in House
text: <p>This bill requires the federal government to create a mechanism through which insulin manufacturers may sell their products directly to consumers at current net prices.</p>

tv_txt: I 116th CONGRESS 1st Session H. R. 5382 IN THE HOUSE OF REPRESENTATIVES December 10, 2019 Mr. Fortenberry introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

The U.S. Government shall create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.